Table 2.
Method purpose | Example/outcome | Sub-studies | Analytical parameters |
---|---|---|---|
Measure immediate lethality effects | • KD and 24 h mortality |
• Define test conditions (P) • Replication • Comparison* |
• Robustness (P) • Precision |
Quantify downstream outcomes |
• Delayed mortality (72–96 h) • Impacts on fecundity |
• Define test conditions (P) • Replication • Comparison* |
• Robustness (P) • Precision |
Monitor success/failure of an outcome during exposure | • Blood-feeding success |
• Define test conditions (P) • Replication • Comparison* |
• Robustness (P) • Precision |
Measure induced sterility | • Oviposition inhibition |
• Define test conditions (P) • Replication • Comparison* |
• Robustness (P) • Precision |
Characterize behavioural responses during- and post-exposure | • Proportion of net contact time |
• Define test conditions (P) • Replication • Comparison* |
• Robustness (P) • Precision |
Monitor durability |
• Efficacy of ITNs after 3 years deployment • Duration of IRS efficacy |
• Define test conditions (P) • Linearity and reportable range • Comparison* |
• Robustness (P) • Linearity • Range • Precision |
Evaluate combination products | • ITN with different concentration/s of AI/s on different parts of the net | • As per method purpose for each combination | • As per method purpose for each combination |
P Preliminary development phase
*If applicable